<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">transmed</journal-id><journal-title-group><journal-title xml:lang="ru">Трансляционная медицина</journal-title><trans-title-group xml:lang="en"><trans-title>Translational Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2311-4495</issn><issn pub-type="epub">2410-5155</issn><publisher><publisher-name>Almazov National Medical Research Centre, Saint Petersburg, Russia</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18705/2311-4495-2018-5-2-15-21</article-id><article-id custom-type="elpub" pub-id-type="custom">transmed-382</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>СЕРДЕЧНО-СОСУДИСТЫЕ ЗАБОЛЕВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CARDIOVASCULAR MEDICINE</subject></subj-group></article-categories><title-group><article-title>РЕМОДЕЛИРОВАНИЕ МИОКАРДА У ПАЦИЕНТОВ  С ФИБРИЛЛЯЦИЕЙ ПРЕДСЕРДИЙ ПРИ ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ</article-title><trans-title-group xml:lang="en"><trans-title>MYOCARDIAL REMODELING IN PATIENTS WITH ATRIAL FIBRILLATION IN CHRONIC HEART FAILURE</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6254-0756</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кириллова</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kirillova</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кириллова Венера Вячеславовна - кандидат медицинских наук, старший научный сотрудник, лаборатория антивозрастных технологий, Институт медицинских клеточных технологий; ассистент кафедры биохимии ФГБОУ ВО УГМУ МинздраваРФ; зав. отд. ранней диагностики и лечения хронической сердечной недостаточности, ООО Клиника «Уральская».</p><p>Ул. Карла Маркса, д. 22 а, Екатеринбург, 620026</p></bio><bio xml:lang="en"><p>Venera V. Kirillova - MD, PhD, senior researcher, Institute for medical cell technologies.</p><p>Karla Marksa str., 22 a, Ekaterinburg, 620026</p></bio><email xlink:type="simple">venova@list.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ГАУЗ СО Институт медицинских клеточных технологий; ФГБОУ ВО Уральский государственный медицинский университет Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Institute for medical cell technologies; Ural state medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>17</day><month>06</month><year>2018</year></pub-date><volume>5</volume><issue>2</issue><fpage>15</fpage><lpage>21</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Кириллова В.В., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Кириллова В.В.</copyright-holder><copyright-holder xml:lang="en">Kirillova V.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://transmed.almazovcentre.ru/jour/article/view/382">https://transmed.almazovcentre.ru/jour/article/view/382</self-uri><abstract><p>Неудовлетворенность результатами медикаментозной и немедикаментозной терапии фибрилляции предсердий заставляет клиницистов и ученых искать новые методы лечения этой аритмии.</p><sec><title>Цель исследования</title><p>Цель исследования: изучить особенности ремоделирования сердца и характер морфологических изменений миокарда у пациентов с хронической сердечной недостаточностью при фибрилляции предсердий.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. У пациентов с фибрилляцией предсердий при хронической сердечной недостаточности, имеющих и не имеющих фибрилляцию предсердий изучались эхокардиографически особенности ремоделирования миокарда и микроскопически морфология миокарда сегмента ушка правого предсердия.</p></sec><sec><title>Результаты</title><p>Результаты. У пациентов с хронической сердечной недостаточностью, имеющих фибрилляцию предсердий, по сравнению с пациентами, не имеющими нарушение ритма, выявлены более выраженные гипертрофия стенок миокарда левого и правого желудочков, дилатация обоих предсердий и левого желудочка, повышенное давление в легочной артерии и венах. При постоянной форме в отличие от пароксизмальной формы фибрилляции предсердий структурные нарушения стенок и камер сердца более выражены. Выявлен интерстициальный отек миокарда ушка правого предсердия у пациентов с фибрилляцией предсердий по сравнению с пациентами без нарушений ритма.</p></sec><sec><title>Выводы</title><p>Выводы. Более выраженная дилатация предсердий у пациентов с фибрилляцией предсердий при хронической сердечной недостаточности сопровождается интерстициальным отеком миокарда, который, возможно, и является одной из причин возникновения и поддержания фибрилляции предсердий.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Background</title><p>Background. Dissatisfaction with the results of drug and non-drug therapy of atrial fibrillation causes clinicians and scientists to seek new methods for treatment of this arrhythmia.</p></sec><sec><title>Objective</title><p>Objective. The paper aims at studying the features of cardiac remodeling and morphological changes of myocardium in chronic heart failure patients with atrial fibrillation.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. The features myocardial remodeling and the morphology of the myocardium of a right atrial auricle segment were studied, respectively, by echocardiography and by microscopy in chronic heart failure patients with and without atrial fibrillation.</p></sec><sec><title>Results</title><p>Results. Compared to patients without cardiac arrhythmia, patients with chronic heart failure, with atrial fibrillation, revealed more pronounced hypertrophy of the walls of the myocardium of the left and right ventricles, increased myocardial mass index, dilatation of both right and left atria, increased pressure in the pulmonary artery and veins. With a constant form, unlike paroxysmal atrial fibrillation, structural disorders of the walls and chambers of the heart were more pronounced. The interstitial edema of the myocardium of the auricle of the right atrium was detected in patients with atrial fibrillation compared to patients without arrhythmias.</p></sec><sec><title>Conclusion</title><p>Conclusion. More pronounced atrial dilatation in heart failure patients with atrial fibrillation is accompanied by interstitial myocardial edema, which, perhaps, is one of the reasons for the emergence and maintenance of atrial fibrillation.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>фибрилляция предсердий</kwd><kwd>пароксизмальная форма</kwd><kwd>постоянная форма</kwd><kwd>дилатация предсердий</kwd><kwd>интерстициальный отек миокарда</kwd></kwd-group><kwd-group xml:lang="en"><kwd>atrial fibrillation</kwd><kwd>paroxysmal form</kwd><kwd>constant form</kwd><kwd>atrial dilatation</kwd><kwd>interstitial myocardial edema</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893-2962.</mixed-citation><mixed-citation xml:lang="en">Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893-2962.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med. 1982;306(17):1018-1022.</mixed-citation><mixed-citation xml:lang="en">Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med. 1982;306(17):1018-1022.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Steinberg BA, Holmes DN, Ezekowitz MD, et al. Rate versus rhythm control for management of atrial fibrillation in clinical practice: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. Am Heart J. 2013;165:622–629.</mixed-citation><mixed-citation xml:lang="en">Steinberg BA, Holmes DN, Ezekowitz MD, et al. Rate versus rhythm control for management of atrial fibrillation in clinical practice: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. Am Heart J. 2013;165:622–629.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Choi YJ, Kang KW, Kim TH, et al. Comparison of Rhythm and Rate Control Strategies for Stroke Occurrence in a Prospective Cohort of Atrial Fibrillation Patients. Yonsei Med J. 2018; 59(2): 258–264.</mixed-citation><mixed-citation xml:lang="en">Choi YJ, Kang KW, Kim TH, et al. Comparison of Rhythm and Rate Control Strategies for Stroke Occurrence in a Prospective Cohort of Atrial Fibrillation Patients. Yonsei Med J. 2018; 59(2): 258–264.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">AFFIRM Investigators. Atrial Fibrillation Followup Investigation of Rhythm Management. Baseline characteristics of patients with atrial fibrillation: the AFFIRM Study. Am Heart J. 2002;143(6):991-1001.</mixed-citation><mixed-citation xml:lang="en">AFFIRM Investigators. Atrial Fibrillation Followup Investigation of Rhythm Management. Baseline characteristics of patients with atrial fibrillation: the AFFIRM Study. Am Heart J. 2002;143(6):991-1001.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Perez FJ, Lung TH, Ellenbogen KA, et al. Is time to first recurrence of atrial fibrillation correlated with atrial fibrillation burden? Am J Cardiol 2006; 97(9): 1343-1345.</mixed-citation><mixed-citation xml:lang="en">Perez FJ, Lung TH, Ellenbogen KA, et al. Is time to first recurrence of atrial fibrillation correlated with atrial fibrillation burden? Am J Cardiol 2006; 97(9): 1343-1345.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ganesan AN, Shipp NJ, Brooks AG, et al. Longterm outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis. J Am Heart Assoc. 2013; 2(2): e004549.</mixed-citation><mixed-citation xml:lang="en">Ganesan AN, Shipp NJ, Brooks AG, et al. Longterm outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis. J Am Heart Assoc. 2013; 2(2): e004549.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Spragg DD, Dalal D, Cheema A, et al. Complications of catheter ablation for atrial fibrillation: incidence and predictors. J. Cardiovasc. Electrophysiol. 2008; 19(6): 627-631.</mixed-citation><mixed-citation xml:lang="en">Spragg DD, Dalal D, Cheema A, et al. Complications of catheter ablation for atrial fibrillation: incidence and predictors. J. Cardiovasc. Electrophysiol. 2008; 19(6): 627-631.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Baman TS, Jongnarangsin K, Chugh, A et al. Prevalence and predictors of complications of radiofrequency catheter ablation for atrial fibrillation. J. Cardiovasc. Electrophysiol. 2011; 22: 626-631.</mixed-citation><mixed-citation xml:lang="en">Baman TS, Jongnarangsin K, Chugh, A et al. Prevalence and predictors of complications of radiofrequency catheter ablation for atrial fibrillation. J. Cardiovasc. Electrophysiol. 2011; 22: 626-631.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal. 2016; 37(27): 2129–2200.</mixed-citation><mixed-citation xml:lang="en">Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal. 2016; 37(27): 2129–2200.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Мареев В.Ю., Фомин И.В., Агеев Ф.Т. и др. Клинические рекомендации. Хроническая сердечная недостаточность (ХСН). Журнал Сердечная Недостаточность. 2017;18 (1):3–40.</mixed-citation><mixed-citation xml:lang="en">Mareev VYu, Fomin IV, Ageev FT, et al. Clinical guidelines. Chronic heart failure (CHF). Russian Heart Failure Journal. 2017;18(1):3–40. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Кириллова В.В. Ранняя ультразвуковая диагностика венозного застоя в малом круге кровообращения у пациентов с хронической сердечной недостаточностью. Журнал Сердечная недостаточность. 2017;18(3):208-212.</mixed-citation><mixed-citation xml:lang="en">Kirillova VV. Early ultrasound detection of venous congestion in pulmonary circulation in patients with chronic heart failure. Russian Heart Failure Journal. 2017;18(3):208-212. (In Russian)</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Акаемова О.Н., Коц Я.И., Железнов Л.М. и др. Клинико-морфологические изменения венозной системы сердца в зависимости от стадии хронической сердечной недостаточности. Кардиология. 2010; 3:51—55.</mixed-citation><mixed-citation xml:lang="en">Аkaemova ON, Kots YaI, Zheleznov LM, et al. Clinical and morphological changes in the venous system of the heart, depending on the stage of chronic heart failure. Cardiology. 2010; 3:51—55. In Russian.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
